Investigation of dendritic mesoporous silica nanoparticles for cytosine-phosphate-guanosine oligodeoxynucleotide delivery

Yi Xu,Yufang Zhu,Xianglan Li,Hiromi Morita,Nobutaka Hanagata
DOI: https://doi.org/10.1166/mex.2016.1288
2016-01-01
Materials Express
Abstract:Dendritic mesoporous silica nanoparticles (DMSNs) with average particle sizes of 97, 205, and 535 nm have been synthesized to deliver cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODNs). DMSNs with center-radial pore channels were modified with 3-aminopropyltriethoxysilane (APTES) to produce DMSN97-NH2, DMSN205-NH2 and DMSN535-NH2 nanoparticles. CpG ODNs were bonded to the aminated nanoparticles to form DMSN97-NH2/CpG, DMSN205-NH2/CpG and DMSN535-NH2/CpG complexes. For each complex, serum stability, in vitro cytotoxicity, cellular uptake, and cytokine interleukin-6 (IL-6) induction were investigated. All aminated DMSNs had no cytotoxicity to Raw 264.7 cells and enhanced the serum stability of CpG ODNs. The DMSN97-NH2/CpG, DMSN205-NH2/CpG, and DMSN535-NH2/CpG complexes were taken up by cells and were located in endolysosomes, which is beneficial for interactions with Toll-like receptor 9 (TLR9). Based on a cytokine induction assay, all of the complexes significantly enhanced IL-6 induction compared to free CpG ODNs, but the DMSN97-NH2/CpG complexes exhibited the highest IL-6 induction ability. Therefore, DMSNs with small particle sizes are particularly promising for CpG ODN delivery.
What problem does this paper attempt to address?